US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 192 actively recruiting studies with Wisconsin sites out of 192 registered in total. The busiest research areas in Wisconsin are Acute Myeloid Leukemia, Breast Cancer, Heart Failure. Leading sponsors running trials in the state include University of Wisconsin, Madison, National Cancer Institute (NCI), Medical College of Wisconsin. By stage, Wisconsin trials break down as Phase 1 (26), Phase 2 (44), Phase 3 (59), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
192
Recruiting Now
192
← Back to US Map
Top Conditions in Wisconsin
Acute Myeloid Leukemia (4)Breast Cancer (4)Heart Failure (4)Multiple Myeloma (3)Chronic Lymphocytic Leukemia (3)Ovarian Cancer (3)Pancreatic Adenocarcinoma (3)Stage III Pancreatic Cancer AJCC v8 (3)Advanced Solid Tumors (2)Advanced Solid Tumor (2)Non-Small Cell Lung Cancer (NSCLC) (2)Endometrial Cancer (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 192 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 192. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Breast Cancer, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT04172532 Phase 1, Phase 2
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
92 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06771830 N/A
Recruiting
Evaluation of Pediatric eCART Implementation
Condition
Pediatric ALL
Enrollment
30,000 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06658899 Phase 2
Recruiting
A Phase 2 Study of CRD-4730 in CPVT
Condition
Catecholaminergic Polymorphic Ventricular Tachycardia
Enrollment
12 pts
Location
United States, Canada, France
Sponsor
Cardurion Pharmaceuticals, Inc
View Trial →
NCT05877599 Phase 1
Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Posi...
Condition
Non-small Cell Lung Cancer
Enrollment
45 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05168163 Phase 2
Recruiting
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of U...
Condition
Locally Advanced Hepatocellular Carcinoma
Enrollment
122 pts
Location
United States
Sponsor
Academic and Community Cancer
View Trial →
NCT07118306 N/A
Recruiting
COPD Exacerbation Follow Up
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
485 pts
Location
United States
Sponsor
Viz.ai, Inc.
View Trial →
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
View Trial →
NCT06311214 Phase 2
Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing fo...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07326709 Phase 3
Recruiting
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Part...
Condition
Huntington Disease
Enrollment
770 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05966493 Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic G...
Condition
Persistent Corneal Epithelial Defect
Enrollment
84 pts
Location
United States, Germany, Italy
Sponsor
Glaukos Corporation
View Trial →
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06866964 Phase 2
Recruiting
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboemboli...
Condition
Germ Cell Tumor
Enrollment
35 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT03150693 Phase 3
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With N...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
303 pts
Location
United States, Canada
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06779773 N/A
Recruiting
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice ...
Condition
Geographic Atrophy
Enrollment
500 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT07067463 Phase 3
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Condition
Multiple Sclerosis (MS) Primary Progressive
Enrollment
705 pts
Location
United States, Bulgaria, Croatia
Sponsor
Zenas BioPharma (USA), LLC
View Trial →
NCT06998940 Phase 3
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Adva...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
94 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
590 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
View Trial →
NCT05943535 Phase 3
Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progre...
Condition
Progressive Pulmonary Fibrosis
Enrollment
698 pts
Location
United States, Argentina, Australia
Sponsor
United Therapeutics
View Trial →
NCT04559425 N/A
Recruiting
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
Condition
Heart Block Complete
Enrollment
350 pts
Location
United States, Bulgaria, Canada
Sponsor
The Hospital for Sick Children
View Trial →
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
View Trial →
NCT06008197 Phase 3
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mort...
Condition
Heart Failure
Enrollment
5,200 pts
Location
United States, Argentina, Australia
Sponsor
Colorado Prevention Center
View Trial →
NCT07091617 N/A
Recruiting
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing ...
Condition
Miscellaneous Neoplasm, Nos
Enrollment
535 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04718168 N/A
Recruiting
GORE® ENFORM Biomaterial Product Study
Condition
Hernia, Ventral
Enrollment
245 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT06420752 Phase 2
Recruiting
Passive Stretching in Peripheral Arterial Disease Patients
Condition
Peripheral Arterial Disease
Enrollment
64 pts
Location
United States
Sponsor
University of Wisconsin, La Cr
View Trial →
Page 3 of 8 — 192 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology